446 related articles for article (PubMed ID: 18218687)
1. Vascular dysfunction in adriamycin nephrosis: different effects of adriamycin exposure and nephrosis.
Ulu N; Buikema H; van Gilst WH; Navis G
Nephrol Dial Transplant; 2008 Jun; 23(6):1854-60. PubMed ID: 18218687
[TBL] [Abstract][Full Text] [Related]
2. Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and aminonucleoside.
Grond J; Weening JJ; Elema JD
Lab Invest; 1984 Sep; 51(3):277-85. PubMed ID: 6471809
[TBL] [Abstract][Full Text] [Related]
3. Increased glomerular thromboxane synthesis as a possible cause of proteinuria in experimental nephrosis.
Remuzzi G; Imberti L; Rossini M; Morelli C; Carminati C; Cattaneo GM; Bertani T
J Clin Invest; 1985 Jan; 75(1):94-101. PubMed ID: 4038407
[TBL] [Abstract][Full Text] [Related]
4. Steroids and Adriamycin nephrosis.
Bertani T; Remuzzi G; Rocchi G; Delaini F; Sacchi G; Falchetti M; Donati MB
Appl Pathol; 1984; 2(1):32-8. PubMed ID: 6525317
[TBL] [Abstract][Full Text] [Related]
5. Involvement of renal ACE activity in proteinuria-associated renal damage in untreated and treated adriamycin nephrotic rats.
Bos H; Laverman GD; Henning RH; Tiebosch AT; de Jong PE; de Zeeuw D; Navis G
J Renin Angiotensin Aldosterone Syst; 2003 Jun; 4(2):106-12. PubMed ID: 12806593
[TBL] [Abstract][Full Text] [Related]
6. The influence of chronic ethanol administration on adriamycin-induced nephrotic syndrome in rats.
Tesar V; Zima T; Poledne R; Stejskalová A; Stípek S; Tĕmínová J
Alcohol Alcohol; 1995 Jan; 30(1):47-53. PubMed ID: 7748275
[TBL] [Abstract][Full Text] [Related]
7. Individual differences in renal ACE activity in healthy rats predict susceptibility to adriamycin-induced renal damage.
Rook M; Lely AT; Kramer AB; van Goor H; Navis G
Nephrol Dial Transplant; 2005 Jan; 20(1):59-64. PubMed ID: 15572383
[TBL] [Abstract][Full Text] [Related]
8. Administration of pigment epithelium-derived factor (PEDF) reduces proteinuria by suppressing decreased nephrin and increased VEGF expression in the glomeruli of adriamycin-injected rats.
Fujimura T; Yamagishi S; Ueda S; Fukami K; Shibata R; Matsumoto Y; Kaida Y; Hayashida A; Koike K; Matsui T; Nakamura K; Okuda S
Nephrol Dial Transplant; 2009 May; 24(5):1397-406. PubMed ID: 19042927
[TBL] [Abstract][Full Text] [Related]
9. Changes of glomerular fixed anionic charge sites in adriamycin nephrosis in rats.
Wang Z; Wang ZG; Liu Z
Chin Med J (Engl); 1991 Feb; 104(2):128-31. PubMed ID: 1714805
[TBL] [Abstract][Full Text] [Related]
10. Renal targeting of captopril using captopril-lysozyme conjugate enhances its antiproteinuric effect in adriamycin-induced nephrosis.
Windt WA; Prakash J; Kok RJ; Moolenaar F; Kluppel CA; de Zeeuw D; van Dokkum RP; Henning RH
J Renin Angiotensin Aldosterone Syst; 2004 Dec; 5(4):197-202. PubMed ID: 15803438
[TBL] [Abstract][Full Text] [Related]
11. Renal endothelial function and blood flow predict the individual susceptibility to adriamycin-induced renal damage.
Ochodnicky P; Henning RH; Buikema H; Kluppel AC; van Wattum M; de Zeeuw D; van Dokkum RP
Nephrol Dial Transplant; 2009 Feb; 24(2):413-20. PubMed ID: 18728153
[TBL] [Abstract][Full Text] [Related]
12. [Relationship between glomerular nephrin expression and oxidative stress reaction in rats with adriamycin-induced nephrosis].
Zhu Y; Lu L
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jan; 11(1):56-60. PubMed ID: 19149925
[TBL] [Abstract][Full Text] [Related]
13. [The effect of chronic administration of ethanol on experimental adriamycin nephropathy].
Tesar V; Zima T; Poledne R; Stejskalová A; Stípek S; Tĕmínová J
Cas Lek Cesk; 1994 May; 133(9):268-71. PubMed ID: 8194094
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of deferoxamine, N-acetylcysteine and selenium treatments in rats with Adriamycin-induced nephrotic syndrome.
Bulucu F; Oktenli C; Kenar L; Ocal R; Koc B; Inal V; Yamanel L; Yaman H; Sanisoglu YS; Aydin A
J Nephrol; 2008; 21(4):576-83. PubMed ID: 18651549
[TBL] [Abstract][Full Text] [Related]
15. Messenger RNA expressions of vasopressin system and aquaporin-2 in adriamycin-induced nephrotic rats and effects of astragalus membranaceus.
Ma J; Fan S; Chen J; Gu Y; Lin S
Chin Med J (Engl); 1999 Dec; 112(12):1068-72. PubMed ID: 11721440
[TBL] [Abstract][Full Text] [Related]
16. Effects of anti-proteinuric therapy with angiotensin-converting-enzyme inhibition on renal protein catabolism in the adriamycin-induced nephrotic rat.
Haas M; de Boer E; de Jong PE; Moolenaar F; Meijer DK; de Zeeuw D
Clin Sci (Lond); 2003 Jul; 105(1):51-7. PubMed ID: 12636872
[TBL] [Abstract][Full Text] [Related]
17. Inter-individual differences in anti-proteinuric response to ACEi in established adriamycin nephrotic rats are predicted by pretreatment renal damage.
Kramer AB; Laverman GD; van Goor H; Navis G
J Pathol; 2003 Sep; 201(1):160-7. PubMed ID: 12950029
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of antithrombin on puromycin aminonucleoside nephrosis in rats.
Yamashita J; Nakajima K; Ohno Y; Kaneshiro Y; Matsuo T; Tanaka H; Kaneko K
Eur J Pharmacol; 2008 Jul; 589(1-3):239-44. PubMed ID: 18541230
[TBL] [Abstract][Full Text] [Related]
19. Proinflammatory role of angiotensin II in a rat nephrosis model induced by adriamycin.
Muñoz M; Rincón J; Pedreañez A; Viera N; Hernández-Fonseca JP; Mosquera J
J Renin Angiotensin Aldosterone Syst; 2011 Dec; 12(4):404-12. PubMed ID: 21705470
[TBL] [Abstract][Full Text] [Related]
20. Treatment of experimental nephrotic syndrome with artesunate.
Razavi A; Nouri HR; Mehrabian F; Mirshafiey A
Int J Toxicol; 2007; 26(4):373-80. PubMed ID: 17661229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
